New Drug By Botox Makers Could Spell The End Of Mascara

The much-loved mascara could soon go into oblivion, thanks to a new drug from the creators of Botox that can enhance dull or thinning lashes.

Created by Allergan, the company behind the anti-wrinkle drug Botox, the new chemical for eyelashes, called Latisse, has been approved by the Food and Drug Administration (FDA) in the US.

Botox - Procedure Indications Side Effects Treatment Conclusion FAQs
Botox injections, the fastest growing cosmetic procedures, are considered as the ultimate fountain of eternal youth.

Latisse has been designed to treat a condition known as hypotrichosis of the eyelashes, which means a person does not have enough eyelashes, reports the Telegraph.

If applied once everyday to the eyelid using a disposable applicator, Latisse can apparently improve the length, thickness and colour of hairs.

The drug should be used regularly to maintain the thicker lashes.

Botox Injections
Botox or Botulinum toxin A is widely employed in the cosmetic industry due to its anti-ageing properties.

Its side effects can include eye redness and itchiness, a darkening of the eyelid skin and a permanent darkening of the whites of the eyes.

The most important ingredient in Latisse is a chemical called a prostaglandin, which is present in hair.

Glaucoma - Causes, Symptoms, Diagnosis, Treatment & Prevention
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in intraocular pressure. Uncontrolled glaucoma can lead to blindness.

The chemical may help in the development and regrowth of hair follicles and is also used to treat glaucoma.

In fact, it was a glaucoma specialist who first discovered the eyelash effect.

Eyelash Lengthener Draws Lashes From FDA
In San Jose, California, officials have confiscated many applicator tubes of Age Intervention Eyelash as they are alleged to cause a decline in eyesight.

Latisse, which is the first prescription product for lengthening eyelashes, will be available early next year and reportedly a 30-day supply of the drug will cost 120 dollars.

According to the company, the global sales of the drug could cross the figure of 300million pounds a year.

Source-ANI
SRM